Verastem’s KRAS inhibitor posts wins in mPDAC, mCRC and NSCLC
Verastem is advancing the KRAS inhibitor into later stage studies following the data readout.
The post Verastem’s KRAS inhibitor posts wins in mPDAC, mCRC and NSCLC appeared first on Clinical Trials Arena .